| NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure CE Murdoch, M Zhang, AC Cave, AM Shah Cardiovascular research 71 (2), 208-215, 2006 | 429 | 2006 |
| Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo R Ray, CE Murdoch, M Wang, CX Santos, M Zhang, S Alom-Ruiz, ... Arteriosclerosis, thrombosis, and vascular biology 31 (6), 1368-1376, 2011 | 363 | 2011 |
| Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition CE Murdoch, S Chaubey, L Zeng, B Yu, A Ivetic, SJ Walker, D Vanhoutte, ... Journal of the American College of Cardiology 63 (24), 2734-2741, 2014 | 183 | 2014 |
| Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction CE Murdoch, SP Alom-Ruiz, M Wang, M Zhang, S Walker, B Yu, A Brewer, ... Basic research in cardiology 106, 527-538, 2011 | 173 | 2011 |
| Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction CE Murdoch, SP Alom-Ruiz, M Wang, M Zhang, S Walker, B Yu, A Brewer, ... Basic research in cardiology 106, 527-538, 2011 | 173 | 2011 |
| NADPH oxidase signaling and cardiac myocyte function A Akki, M Zhang, C Murdoch, A Brewer, AM Shah Journal of molecular and cellular cardiology 47 (1), 15-22, 2009 | 167 | 2009 |
| EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries RJ Davis, CE Murdoch, M Ali, S Purbrick, R Ravid, GS Baxter, N Tilford, ... British journal of pharmacology 141 (4), 580-585, 2004 | 162 | 2004 |
| Involvement of NADPH oxidases in cardiac remodelling and heart failure A Sirker, M Zhang, C Murdoch, AM Shah American journal of nephrology 27 (6), 649-660, 2007 | 115 | 2007 |
| Glutathione adducts induced by ischemia and deletion of glutaredoxin-1 stabilize HIF-1α and improve limb revascularization Y Watanabe, CE Murdoch, S Sano, Y Ido, MM Bachschmid, RA Cohen, ... Proceedings of the National Academy of Sciences 113 (21), 6011-6016, 2016 | 86 | 2016 |
| Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor Z Wang, DJ Stuckey, CE Murdoch, P Camelliti, GYH Lip, M Griffin Cell Death & Disease 9 (6), 613, 2018 | 79 | 2018 |
| NADPH oxidase and heart failure CE Murdoch, DJ Grieve, AC Cave, YH Looi, AM Shah Current opinion in pharmacology 6 (2), 148-153, 2006 | 79 | 2006 |
| Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization CE Murdoch, M Shuler, DJF Haeussler, R Kikuchi, P Bearelly, J Han, ... Journal of Biological Chemistry 289 (12), 8633-8644, 2014 | 70 | 2014 |
| Distinct regulatory effects of myeloid cell and endothelial cell NAPDH oxidase 2 on blood pressure CM Sag, M Schnelle, J Zhang, CE Murdoch, S Kossmann, A Protti, ... Circulation 135 (22), 2163-2177, 2017 | 58 | 2017 |
| Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis J Humphries, JA Gossage, B Modarai, KG Burnand, TH Sisson, ... Journal of vascular surgery 50 (5), 1127-1134, 2009 | 52 | 2009 |
| Development of potent and selective tissue transglutaminase inhibitors: their effect on TG2 function and application in pathological conditions E Badarau, Z Wang, DL Rathbone, A Costanzi, T Thibault, CE Murdoch, ... Chemistry & biology 22 (10), 1347-1361, 2015 | 49 | 2015 |
| Therapeutic angiogenesis of Chinese herbal medicines in ischemic heart disease: a review D Guo, CE Murdoch, T Liu, J Qu, S Jiao, Y Wang, W Wang, X Chen Frontiers in pharmacology 9, 428, 2018 | 47 | 2018 |
| Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction A Sirker, CE Murdoch, A Protti, GJ Sawyer, CXC Santos, D Martin, ... Journal of Molecular and Cellular Cardiology 98, 11-17, 2016 | 46 | 2016 |
| Vascular endothelial growth factor signaling requires glycine to promote angiogenesis D Guo, CE Murdoch, H Xu, H Shi, DD Duan, A Ahmed, Y Gu Scientific Reports 7 (1), 14749, 2017 | 45 | 2017 |
| Constitutive glycogen synthase kinase-3α/β activity protects against chronic β-adrenergic remodelling of the heart IG Webb, Y Nishino, JE Clark, C Murdoch, SJ Walker, MR Makowski, ... Cardiovascular research 87 (3), 494-503, 2010 | 43 | 2010 |
| Constitutive glycogen synthase kinase-3α/β activity protects against chronic β-adrenergic remodelling of the heart IG Webb, Y Nishino, JE Clark, C Murdoch, SJ Walker, MR Makowski, ... Cardiovascular research 87 (3), 494-503, 2010 | 43 | 2010 |
